Benzinga's Top #PreMarket Gainers

Biodel Inc BIOD shares jumped 42.07% to $2.06 in pre-market trading after the company reported positive preliminary results from Phase 2a clinical trial of BIOD-531. BIND Therapeutics, Inc.BIND shares rose 40.78% to $7.25 in pre-market trading after the company provided clinical update for BIND-014. NephroGenex, Inc. NRX shares jumped 14.55% to $10.55 in pre-market trading after the company received positive advice from the European Medicines Agency Regarding its Phase 3 program with Pyridorin. Neurocrine Biosciences Inc. NBIX shares surged 13.30% to $24.79 in pre-market trading after AbbVie Inc. ABBV, in cooperation with Neurocrine Biosciences, announces positive top-line results from Phase 3 study of investigational medicine elagolix. Amicus Therapeutics, Inc.FOLD shares gained 11.24% to $9.50 in the pre-market trading session following the report of additional positive data on important cardiac endpoint.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPre-Market OutlookMarketsMoversBiotechnologyHealth CareTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!